cobas® liat CT/NG/MG

IVD For in vitro diagnostic use.
cobas liat CT/NG/MG

Use left and right arrow keys to scroll between the tabs

Trusted sexual health testing for everybody, in every setting

More than 1 million people worldwide acquire a sexually transmitted infection (STI) every day.1 Mycoplasma genitalium (MG) is an emerging STI among men and women with rapidly evolving antimicrobial resistance. Due to overlapping symptoms of different urogenital infections, diagnosis based on symptoms alone can be challenging and presents a risk of inappropriate treatment.

The cobas® liat CT/NG/MG assay provides differential results for chlamydia, gonorrhea and Mycoplasma genitalium to inform treatment decisions. The test delivers accurate results in 20 minutes, enabling timely diagnosis and improving patient management. 

cobas® liat CT/NG/MG specifications

View Full Table

cobas® liat CT/NG/MG specifications

Instrument

cobas® liat system

Targets

Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG)

Registration

FDA 510(k) cleared, CLIA-waived

Time to result

20 minutes

Sample type

Male urine, vaginal swabs (clinician collected and self-collected in a clinical setting)

Reagents

Ready-to-use, pre-packed tube format

Kit Storage

2–8°C

Collection media

cobas® PCR Media

Technology

Real-time PCR

Sample extraction

Fully automated and integrated

Control

Internal sample processing control, positive and negative controls

cobas® liat CT/NG/MG ordering information

View Full Table

cobas® liat CT/NG/MG ordering information

Material Number

Alternative Catalog Number

Material Description

Pack Size

Pack size Description

09449604190   KIT COBAS LIAT CT/NG/MG 1 pack 20 tests
09449639190   KIT COBAS LIAT CT/NG/MG QC 1 pack 3 sets
07958030190   cobas PCR Media Uni Swab Sample Kit 1 pack 100 uni swab sample packets
05170486190   COBAS PCR MEDIA URINE SAMPLE KIT 1 pack 100 Urine Sample Packets
<b>cobas</b><sup>®</sup> <b>liat</b> CT/NG/MG intended use<sup>2</sup>

cobas® liat CT/NG/MG intended use2

The cobas® liat CT/NG/MG nucleic acid test is an automated, qualitative in vitro nucleic acid diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG) nucleic acid in male urine and vaginal swabs in cobas® PCR Media (Roche Molecular Systems, Inc.).

This test is intended as an aid in the diagnosis of urogenital infections in both symptomatic and asymptomatic individuals.

Would you like to know more about the cobas® liat CT/NG/MG assay?

Please submit your information in the following form to be contacted by a Roche representative with more details about the cobas® liat CT/NG/MG assay.

References

  1. World Health Organization, Sexually Transmitted Infections https://www.who.int/health-topics/sexually-transmitted-infections#tab=tab_1. Accessed 1/14/2025.
  2. cobas® liat CT/NG/MG IVD Instructions for Use

Overview

Detailed Specifications

Ordering Information

Compatible Instruments

...
    ...

    Technical Documents

    error errorMessage
    Sorry, we couldn't find the content you are looking for
    Please try again later